North America Injectable Drug Delivery Market - Industry Trends & Forecast 2024Posted by Bharat Book on August 19th, 2017 North America injectable drug delivery market is expected to reach USD 354.5 billion by 2024 from USD 154.0 billion in 2016, at a CAGR of 11.0% in the forecast period 2017 to 2024. The report contains 289 pages of exclusive premium insights with 135 tables and 46 figures. North America injectable drug delivery market is segmented on the basis of type, applications, usage pattern, mode of administration, end user, and country. Request A Sample copy of North America Injectable Drug Delivery Market @ https://www.bharatbook.com/request-sample/920962 On the basis of applications, the injectable drug delivery market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others. Based on indications, the market is segmented into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis, and others. The North America Injectable Drug Delivery Market is segmented into 3 major countries such as U.S., Canada, Mexico Major Players Operating in North America Injectable Drug Delivery Market: Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, and Teva Pharmaceuticals Industries Ltd., among others. Regions Covered In The Scope Of The Report: North America (U.S., Canada, Mexico) Browse our related reports on above topic : Injectable Drug Delivery Market Report Contact us at: Like it? Share it!More by this author |